Peptic ulceration.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D015738:Famotidine; D017506:H(+)-K(+)-Exchanging ATPase; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D016567:Nizatidine; D009942:Organometallic Compounds / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D011976:Receptors, Muscarinic / Q000187:drug effects; D013392:Sucralfate / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D009942:Organometallic Compounds; D011459:Prostaglandins E, Synthetic; D011976:Receptors, Muscarinic; D013844:Thiazoles; D013392:Sucralfate; D015738:Famotidine; D000251:Adenosine Triphosphatases; D017506:H(+)-K(+)-Exchanging ATPase; C002791:bismuth tripotassium dicitrate; D016567:Nizatidine